AHR and carcinoma: Hashitomoto et al suggest that upregulation of fascin1 in aggressive human carcinomas appears to have a multi-factorial basis but CREB and AhR as specific regulators of fascin1 transcription do not support the hypothesis that β-catenin signaling has a central role (23).